Search Results 571-580 of 18350 for Lactation

1. Safety and Efficacy of IMM 124-E for Patients with Severe Alcoholic Hepatitis - Mayo Clinic

   Subjects who are pregnant or lactating; Significant systemic or major illness, that, in the opinion of the Investigator would preclude the patient from ...

2. A Study of Pyridostigmine in Postural Tachycardia Syndrome - Mayo Clinic

   Pregnant or lactating women; Presence of failure of other organ systems or systemic illness that could affect autonomic function or the patient's ability to ...

3. 18 Months Later - Your Impact Development

   We did the genetic testing and found out, in fact, Andrew was not able to break down the medications the way most individuals would. Because of this, the ...

4. A Multicenter Pragmatic Implementation Study of ECG-AI-Based Clinical Decision Support Software to Identify Low LVEF

   ... lactating) * Digital ECG captured or available within site for ECG-AI analysis at point-of-care. Exclusion Criteria: * Known history of LVEF ≤ 40% * Known ...

5. MMRC Horizon One Adaptive Platform Trial Evaluating Therapies In RRMM - Mayo Clinic

   * Persons who are pregnant or lactating. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 08/05/2025. Questions ...

6. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Pregnant or lactating females. Males and females of reproductive potential who are unwilling to abide by protocol-specified contraceptive methods as defined ...

7. Electrodiagnostic Parameters After Sets Transfer in Patients With Ulnar Compression Neuropathy - Mayo Clinic

   Specify any exclusion related to pregnancy, lactation, or plans to become pregnant. Specify methods for assessing current status and willingness to use ...

8. Clinical Trials - M6620 First in Human Study

   Men with pregnant or lactating partners or partners who plan to become pregnant during the study or within 6 months of the last dose of study drug are excluded ...

9. A Study to Investigate LYL797 in Adults With Solid Tumors - Mayo Clinic

   * Pregnant or lactating/nursing women. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 6/12/2024. Questions ...

10. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

    Pregnant or lactating. Clinically significant abnormal electrocardiogram (ECG) during Screening; e.g., QTcF > 450 ms. Female subjects of childbearing ...